Q39* (p.Gln39Ter) variant of ALK (ALK tyrosine kinase receptor)
Q39* (p.Gln39Ter) in ALK (ALK tyrosine kinase receptor) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes population frequency data and structural context.
Q39* (p.Gln39Ter) variant details
- p.Gln39Ter
- NCI-TCGA Cosmic COSV1012
- Variant assessed as somatic; high impact.
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.854
- CADD 38.00
- UniProt: Variant assessed as somatic; high impact.
- Population evidence available
- Structural context available